About FARE

Food Allergy Research & Education (FARE) works on behalf of the 15 million Americans with food allergies, including all those at risk for life-threatening anaphylaxis. This potentially deadly disease affects 1 in every 13 children in the U.S. – or roughly two in every classroom. FARE’s mission is to improve the quality of life and the health of individuals with food allergies, and to provide them hope through the promise of new treatments. Our work is organized around three core tenets: LIFE – support the ability of individuals with food allergies to live safe, productive lives with the respect of others through our education and advocacy initiatives; HEALTH – enhance the healthcare access of individuals with food allergies to state-of-the-art diagnosis and treatment; and HOPE – encourage and fund research in both industry and academia that promises new therapies to improve the allergic condition.

 

FARE is committed to advancing life-changing and life-saving research that will improve the lives of individuals managing food allergies. The FARE Clinical Network was created in 2015 to accelerate the development of drugs for patients with food allergies as well as improve the quality of care for this serious illness. The FARE Clinical Network, made up of 27 centers of excellence across the country, brings members together for a common goal of ensuring that patients with food allergies have access to state-of-the-art diagnosis, treatments and research. Centers of excellence have developed best practices for the care of patients with food allergies, serve as sites for clinical trials for the development of new therapeutics and contribute to the development of this registry and will contribute to the development of biorepositories.